Identification of RET gene fusion by exon array analyses in "pan-negative" lung cancer from never smokers

Cell Research

Volumn 22, Issue 5, 2012, Pages 928-931

  Li, Fei ^a   Feng, Yan ^a   Fang, Rong ^a   Fang, Zhaoyuan ^a   Xia, Jufeng ^a   Han, Xiangkun ^a   Liu, Xin Yuan ^a   Chen, Haiquan ^b,c   Liu, Hongyan ^a   Ji, Hongbin ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCDC6 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; PROTEIN RET; RET PROTEIN, HUMAN;

DNA MICROARRAY; EXON; GENE FUSION; GENETICS; HUMAN; LETTER; LUNG TUMOR; METABOLISM; PATHOLOGY; SMOKING;

CYTOSKELETAL PROTEINS; EXONS; GENE FUSION; HUMANS; LUNG NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-RET; SMOKING;

EID: 84862812241     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2012.27     Document Type: Letter

References (20)

1. Toh CK, Gao F, Lim WT, et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 2006; 24:2245-2251.
2. Subramanian J, Govindan R. Lung cancer in never smokers: A review. J Clin Oncol 2007; 25:561-570.
3. Herbst RS, Lippman SM. Molecular signatures of lung cancer- -toward personalized therapy. N Engl J Med 2007; 356:76-78.
4. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350:2129-2139.
5. Pao W, Miller VA. Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. J Clin Oncol 2005; 23:2556-2568.
6. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004; 304:1497-1500.
7. Koivunen JP, Mermel C, Zejnullahu K, et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung can- cer. Clin Cancer Res 2008; 14:4275-4283.
8. Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448:561-566.
9. Sun Y, Ren Y, Fang Z, et al. Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. J Clin Oncol 2010; 28:4616-4620.
10. Rikova K, Guo A, Zeng Q, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007; 131:1190-1203.
11. Wang L, Motoi T, Khanin R, et al. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 2012; 51:127-139.
12. Lin E, Li L, Guan Y, et al. Exon array profiling detects EML4- ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol Cancer Res 2009; 7:1466-1476.
13. Grieco M, Santoro M, Berlingieri MT, et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 1990; 60:557-563.
14. Takahashi M. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev 2001; 12:361-373.
15. Fugazzola L, Pilotti S, Pinchera A, et al. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 1995; 55:5617-5620.
16. Santoro M, Melillo RM, Grieco M, et al. The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Cell Growth Differ 1993; 4:77-84.
17. Jhiang SM, Sagartz JE, Tong Q, et al. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 1996; 137:375-378.
18. Santoro M, Chiappetta G, Cerrato A, et al. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 1996; 12:1821-1826.
19. Li C, Fang R, Sun Y, et al. Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers. PLoS One 2011; 6:e28204.
20. Ju YS, Lee WC, Shin JY, et al. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res 2012; 22:436-445.